Open Access 01.12.2020 | Retraction Note
Retraction Note: Receptor tyrosine kinase inhibitor Sunitinib and integrin antagonist peptide HM-3 show similar lipid raft dependent biphasic regulation of tumor angiogenesis and metastasis
Erschienen in: Journal of Experimental & Clinical Cancer Research | Ausgabe 1/2020